Natural Bodybuilding Sarms 99.9% Andarine S4 / Gtx-007
Posted on

Model NO.: 401900-40-1
Market: Globel
MOQ: 10g
Payment: Western Union, Monygram, Bank Wire
Shipping: Hkems, Feedex, DHL
Trademark: taigui
Origin: China
HS Code: 29163920
Model NO.: 401900-40-1
Market: Globel
MOQ: 10g
Payment: Western Union, Monygram, Bank Wire
Shipping: Hkems, Feedex, DHL
Trademark: taigui
Origin: China
HS Code: 29163920
Bodybuilding Powder Andarine / S4

Andarine(S4) CAS;1182367-47-0
Andarine(S4) MW:437.94026
Andarine(S4) Appearance:White powder
Andarine(S4) Function:New generation supplements for gaining mass and cutting edges
Andarine(S4) Quality:98% by HPLC
Andarine(S4) Assay:HPLC;HNRM;LC-MS
Andarine(S4) Packaging Detail:10g,50g,100g,500g,1kg in aluminum foil bags
Andarine(S4) Delivery Detail:5-7days for regular shipping


Usage:
Andarine (GTx-007, S-4) is an investigational selective androgen receptor modulator (SARM) developed by GTX, Inc for treatment of conditions such as muscle wasting, osteoporosis and benign prostatic hypertrophy, using the non-steroidal androgen antagonist bicalutamide as a lead compound.

Andarine is an orally active partial agonist for androgen receptors. It is less potent in both anabolic and androgenic effects than other SARMs. In an animal model of benign prostatic hypertrophy, andarine was shown to reduce prostate weight with similar efficacy to finasteride, but without producing any reduction in muscle mass or anti-androgenic side effects. This suggests that it is able to competitively block binding of dihydrotestosterone to its receptor targets in the prostate gland, but its partial agonist effects at androgen receptors prevent the side effects associated with the anti-androgenic drugs traditionally used for treatment of BPH.

Information of Andarine (S4) :
Andarine is an orally active partial agonist for androgen receptors, S-4 is effective in not only maintaining lean body mass but actually increasing it. Andarine is less potent in both anabolic and androgenic effects than other SARMs. In an animal model of benign prostatic hypertrophy, andarine was shown to reduce prostate weight with similar efficacy to finasteride, but without producing any reduction in muscle mass or anti-androgenic side effects. This suggests that it is able to competitively block binding to its receptor targets in the prostate gland, but its partial agonist effects at androgen receptors prevent the side effects associated with the anti-androgenic drugs traditionally used for treatment of BPH.

Other SARMs
 
Name CAS NO. Usage
AICAR 2627-69-2 acts by entering nucleoside pools, significantly increasing levels of adenosine 
during periods of ATP breakdown
MK2866 841205-47-8 medical prescription for prevention of cachexia, atrophy, and sarcopenia and 
for Hormone or Testoserone Replacement Therapy.
MK-677 15972-10-0  
for the treatment of frailty in the elderly
LGD-4033 1165910-22-4 pharmacological profile similar to that of enobosarm, Ostarine,MK-2866
GW1516 317318-70-0 For obesity, diabetes, dyslipidemia and cardiovascular disease
Andarine(S4) 401900-40-0 partial agonist, intended mainly for treatment of benign prostatic hypertrophy
SR9009 1379686-30-2 under development at The Scripps Research Institute (TSRI), 
increases the level of metabolic activity in skeletal muscles of mice
RAD140 1182367-47-0 New generation for gaining mass and cutting edges
YK11 431579-34-9 YK11: a SARM and myostatin inhibitor in one
 
AC262356 870888-46-3 New SARMS
SR9011 1379686-29-9 New SARMS
S23 1010396-29-8 New SARMS
GW0724 317318-84-6 New SARMS


Natural Bodybuilding Sarms 99.9% Andarine S4 / Gtx-007
  Bodybuilding Powder Andarine / S4

Andarine(S4) CAS;1182367-47-0
Andarine(S4) MW:437.94026
Andarine(S4) Appearance:White powder
Andarine(S4) Function:New generation supplements for gaining mass and cutting edges
Andarine(S4) Quality:98% by HPLC
Andarine(S4) Assay:HPLC;HNRM;LC-MS
Andarine(S4) Packaging Detail:10g,50g,100g,500g,1kg in aluminum foil bags
Andarine(S4) Delivery Detail:5-7days for regular shipping


Usage:
Andarine (GTx-007, S-4) is an investigational selective androgen receptor modulator (SARM) developed by GTX, Inc for treatment of conditions such as muscle wasting, osteoporosis and benign prostatic hypertrophy, using the non-steroidal androgen antagonist bicalutamide as a lead compound.

Andarine is an orally active partial agonist for androgen receptors. It is less potent in both anabolic and androgenic effects than other SARMs. In an animal model of benign prostatic hypertrophy, andarine was shown to reduce prostate weight with similar efficacy to finasteride, but without producing any reduction in muscle mass or anti-androgenic side effects. This suggests that it is able to competitively block binding of dihydrotestosterone to its receptor targets in the prostate gland, but its partial agonist effects at androgen receptors prevent the side effects associated with the anti-androgenic drugs traditionally used for treatment of BPH.

Information of Andarine (S4) :
Andarine is an orally active partial agonist for androgen receptors, S-4 is effective in not only maintaining lean body mass but actually increasing it. Andarine is less potent in both anabolic and androgenic effects than other SARMs. In an animal model of benign prostatic hypertrophy, andarine was shown to reduce prostate weight with similar efficacy to finasteride, but without producing any reduction in muscle mass or anti-androgenic side effects. This suggests that it is able to competitively block binding to its receptor targets in the prostate gland, but its partial agonist effects at androgen receptors prevent the side effects associated with the anti-androgenic drugs traditionally used for treatment of BPH.

Other SARMs
 
Name CAS NO. Usage
AICAR 2627-69-2 acts by entering nucleoside pools, significantly increasing levels of adenosine 
during periods of ATP breakdown
MK2866 841205-47-8 medical prescription for prevention of cachexia, atrophy, and sarcopenia and 
for Hormone or Testoserone Replacement Therapy.
MK-677 15972-10-0  
for the treatment of frailty in the elderly
LGD-4033 1165910-22-4 pharmacological profile similar to that of enobosarm, Ostarine,MK-2866
GW1516 317318-70-0 For obesity, diabetes, dyslipidemia and cardiovascular disease
Andarine(S4) 401900-40-0 partial agonist, intended mainly for treatment of benign prostatic hypertrophy
SR9009 1379686-30-2 under development at The Scripps Research Institute (TSRI), 
increases the level of metabolic activity in skeletal muscles of mice
RAD140 1182367-47-0 New generation for gaining mass and cutting edges
YK11 431579-34-9 YK11: a SARM and myostatin inhibitor in one
 
AC262356 870888-46-3 New SARMS
SR9011 1379686-29-9 New SARMS
S23 1010396-29-8 New SARMS
GW0724 317318-84-6 New SARMS


Natural Bodybuilding Sarms 99.9% Andarine S4 / Gtx-007
Â